HLA sensitization in ventricular assist device recipients: Does type of device make a difference

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1800-1807

  Kumpati, Ganesh S ^a   Cook, Daniel J ^a   Blackstone, Eugene H ^a   Rajeswaran, Jeevanantham ^a   Abdo, Ashraf S ^a   Young, James B ^a   Starling, Randall C ^a   Smedira, Nicholas G ^a   McCarthy, Patrick M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANTIGEN ANTIBODY REACTION; ARTICLE; COMPARATIVE STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART ASSIST DEVICE; HLA SYSTEM; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE;

EID: 2642556415     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.01.014     Document Type: Article

References (25)

1. Bishay ES, Cook DJ, Starling RC, Ratliff NB Jr, White J, Blackstone EH, et al. The clinical significance of flow cytometry crossmatching in heart transplantation. Eur J Cardiothorac Surg. 2000;17:362-9.
2. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 1999;354:550-5.
3. Itescu S, Ankersmit JH, Kocher AA, Schuster MD. Immunology of left ventricular assist devices. Prog Cardiovasc Dis. 2000;43:67-80.
4. Schuster M, Kocher A, Lietz K, Ankersmit J, John R, Edwards N, et al. Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. Transplant Proc. 2001;33:1960-1.
5. Massad MG, Cook DJ, Schmitt SK, Smedira NG, McCarthy JF, Vargo RL, et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg. 1997;64:1120-5.
6. Moazami N, Itescu S, Williams MR, Argenziano M, Weinberg A, Oz MC. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant. 1998;17:876-80.
7. Diggle PJ, Heagerty PJ, Liang KY, Zeger SL. Analysis of longitudinal data. 2nd ed. New York: Oxford University Press; 2002.
8. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-63.
9. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc Surg. 2002;123:8-15.
10. Addonizio VP Jr, Macarak J, Nicolaou KC, Edmunds LH Jr, Colman RW. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Blood. 1979;53:103-342.
11. Packham MA, Evans G, Glynn MF, Mustard JF. The effect of plasma proteins on the interaction of platelets with glass surfaces. J Lab Clin Med. 1969;73:686-97.
12. Salzman EW, Merrill EW, Binder A, Wolf CF, Ashford TP, Austen WG. Protein-platelet interaction on heparinized surfaces. J Biomed Mater Res. 1969;3:69-81.
13. Johnson MR, Naftel DC, Hobbs RE, Kobashigawa JA, Pitts DE, Levine TB, et al. The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1997;16:801-12.
14. van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood. 1991;77:201-5.
15. Himmelreich G, Ullmann H, Riess H, Rosch R, Loebe M, Schiessler A, et al. Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. ASAIO J. 1995;41:M790-4.
16. Wang IW, Kottke-Marchant K, Vargo RL, McCarthy PM. Hemostatic profiles of HeartMate ventricular assist device recipients. ASAIO J. 1995;41:M782-7.
17. Livingston ER, Fisher CA, Bibidakis EJ, Pathak AS, Todd BA, Furukawa S, et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996;94:II227-34.
18. Spanier T, Oz M, Levin H, Weinberg A, Stamatis K, Stern D, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 1996;112:1090-7.
19. Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus Q, Burton NA, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90:II87-91.
20. Graham TR, Dasse K, Coumbe A, Salih V, Marrinan MT, Frazier OH, et al. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg. 1990;4:182-90.
21. Rafii S, Oz MC, Seldomridge JA, Ferris B, Asch AS, Nachman RL, et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg. 1995;60:1627-32.
22. Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg. 1999;118:404-13.
23. Ankersmit HJ, Wieselthaler G, Moser B, Gerlitz S, Roth G, Boltz-Nitulescu G, et al. Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. J Thorac Cardiovasc Surg. 2002;123:557-61.
24. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-24.
25. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the Twenty-sixth Annual SAS Users Group International Conference. Cary (NC): SAS Institute Inc; 2001. p. 214-26.